DOLOPHINE Drug Patent Profile
✉ Email this page to a colleague
When do Dolophine patents expire, and when can generic versions of Dolophine launch?
Dolophine is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in DOLOPHINE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dolophine
A generic version of DOLOPHINE was approved as methadone hydrochloride by HIKMA on March 8th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOLOPHINE?
- What are the global sales for DOLOPHINE?
- What is Average Wholesale Price for DOLOPHINE?
Summary for DOLOPHINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for DOLOPHINE |
| What excipients (inactive ingredients) are in DOLOPHINE? | DOLOPHINE excipients list |
| DailyMed Link: | DOLOPHINE at DailyMed |
US Patents and Regulatory Information for DOLOPHINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | DOLOPHINE HYDROCHLORIDE | methadone hydrochloride | SYRUP;ORAL | 006134-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | DOLOPHINE HYDROCHLORIDE | methadone hydrochloride | TABLET;ORAL | 006134-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | DOLOPHINE HYDROCHLORIDE | methadone hydrochloride | TABLET;ORAL | 006134-010 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
